Featured Post from Augusta University

July 28 is World Hepatitis Day – let our experts help with your coverage

Jul 17, 2019

1 min

Jose Vazquez, MD



Later this month, countries across the planet will acknowledge World Hepatitis Day in an effort to locate the “missing millions” and one day find a cure for this potentially debilitating and sometimes deadly disease.


“Worldwide, 300 million people are living with viral hepatitis unaware. Without finding the undiagnosed and linking them to care, millions will continue to suffer, and lives will be lost. On World Hepatitis Day, we call on people from across the world to take action and raise awareness to find the ‘missing millions.’” WorldHepatitisDay.org


According to the Centers for Disease Control and Prevention, 25 states in the U.S. have seen Hepatitis A outbreaks since 2017, with 22,028 confirmed cases and 216 deaths. Twenty-three of those outbreaks are still considered ongoing, including in Georgia, which has seen two deaths and 487 cases.


  • Are you a reporter covering health, infectious diseases or outbreaks?
  • Do you need to know more about the signs, symptoms and causes of hepatitis?
  • How is it spread, who is most affected and what are the treatments?


There is a lot to learn and that’s where our experts can help.


Dr. Jose Vazquez is Chief of the Division of Infectious Diseases at the Medical College of Georgia at Augusta University and AU Medical Center. He studies and treats infectious diseases, including hepatitis. A leader in his field and a go-to expert for media regarding this topic, Dr. Vasquez is available to speak with media – simply click on his icon to arrange an interview.



Connect with:
Jose Vazquez, MD

Jose Vazquez, MD

Infectious Diseases

Dr. Jose Vazquez studies and treats infectious diseases, including COVID-19, antibiotic-resistant superbugs and fungal infections.

CoronavirusTranslational Medicine in Infectious DiseasesDrug-Resistant Infections (CREs, KPCs)Infectious Disease Clinical TrialsAntimicrobials and Antifungals
Powered by

You might also like...

Check out some other posts from Augusta University

Can a Mother's ZIP Code Shape a Baby's Future? featured image

2 min

Can a Mother's ZIP Code Shape a Baby's Future?

Where an expectant mother lives might reveal important clues about her baby's health before birth. According to a recent Augusta University Jagwire article, researchers at the Medical College of Georgia have found that mapping birth outcomes by ZIP code can help identify communities where mothers and newborns face greater health risks, providing valuable information for healthcare providers and public health officials. The two-part study out of the Department of Anesthesiology and Perioperative Medicine at the Medical College of Georgia at Augusta University, led by Mary Arthur, MD, explored the relationship between neighborhood characteristics and neonatal outcomes. By combining geographic mapping with maternal and infant health data, the researchers identified areas with higher rates of adverse birth outcomes and examined how factors such as access to prenatal care and other social determinants of health might contribute to those disparities. The findings suggest that geographic data can become a valuable tool for improving maternal and infant health. By identifying communities at greater risk, healthcare systems and policymakers can better target prenatal education, outreach programs and healthcare resources to support expectant mothers before complications arise. For journalists covering maternal health, healthcare disparities and public policy, Arthur offers valuable insight into how community-level data can help guide interventions that improve pregnancy outcomes and give more babies a healthier start in life. "The maps make it very easy to visualize those ZIP codes that link to poor neonatal outcomes. They're also helpful for planning strategic interventions to help the people who live in those particular areas in terms of making sure there are outreach programs for mothers in those areas to have access to prenatal care." Mary Arthur, MD To learn more about this important research and connect with Mary Arthur, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Can One Gene Change the Future of Heart Disease? featured image

2 min

Can One Gene Change the Future of Heart Disease?

Heart disease remains the world's leading cause of death, but researchers are continuing to uncover the genetic mechanisms that drive it. According to a recent Augusta University Jagwire article highlighting new research, scientists are investigating how a little-studied gene might influence the development of cardiovascular disease and whether it could become a future target for treatment. At the center of the research is Kunzhe Dong, PhD, an investigator at Augusta University's Immunology Center of Georgia, who is examining the role of the SH3BGRL2 gene in cardiovascular cells. While the gene has previously been associated with cancer biology, early findings suggest it might also play an important role in regulating how blood vessels respond to stress and injury. Understanding that relationship could reveal new biological pathways involved in heart disease and identify novel opportunities for precision medicine. The research aims to determine how changes in gene expression affect the function of cardiovascular cells and contribute to disease progression. By better understanding these molecular mechanisms, scientists hope to identify new therapeutic targets and improve the ability to prevent or treat cardiovascular disease before irreversible damage occurs. The work also reflects a broader shift toward precision medicine, where treatments are tailored to the underlying biology of each patient rather than relying solely on traditional risk factors. "This gene is well known in one field, but now we're seeing it's also important in cardiovascular cells." Kunzhe Dong, PhD To learn more about this research and connect with Kunzhe Dong, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Heart Disease's Hidden Immune Players Come Into Focus featured image

2 min

Heart Disease's Hidden Immune Players Come Into Focus

Heart disease has long been linked to familiar risk factors such as high cholesterol, high blood pressure and lifestyle choices. But according to a recent Augusta University Jagwire article highlighting research published in Nature Reviews Cardiology, the immune system might also play a critical role in determining how cardiovascular disease develops and progresses. The review, led by Ishita Tandon, PhD, Hossam Abdelsamed, PhD, and Alaa M. Khalifa, PhD, examines the emerging role of CD8+ T cells, specialized immune cells best known for fighting infections, in atherosclerosis, the chronic inflammatory disease responsible for most heart attacks and strokes. By synthesizing the latest evidence, the researchers show how different populations of these immune cells can either fuel inflammation or help regulate it, revealing new opportunities to better understand, diagnose and eventually treat cardiovascular disease. The review also identifies important gaps in current knowledge and outlines promising directions for future research. As scientists continue to better understand how these immune cells behave within arterial plaques, their discoveries could lead to more precise diagnostic tools and a new generation of immune-targeted therapies for cardiovascular disease. Together, the researchers' work offers journalists valuable insight into one of the fastest-evolving areas of cardiovascular research, where immunology and heart health are converging to reshape how cardiovascular disease is understood and treated. "This study highlights the major role of CD8+ T cells in atherosclerosis and their potential impact on cardiovascular diseases."  Hossam Abdelsamed, PhD To learn more about this amazing research and connect with Ishita Tandon, Hossam Abdelsamed or Alaa M. Khalifa, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

View all posts
Powered by